US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pharvaris N.V.

16.64

+0.08000.48%

Post-market: 16.640.00000.00%16:04 EDT

Volume:6.24K

Turnover:103.91K

Market Cap:906.77M

PE:-5.47

High:17.19

Open:16.33

Low:16.00

Close:16.56

Loading ...

Overview Company News Filings

Pharvaris Unveils Promising Data on Deucrictibant for Bradykinin-Mediated Angioedema at EAACI Congress 2025

Pharvaris initiated with a Buy at Guggenheim on HAE potential

Guggenheim Initiates Coverage on Pharvaris With Buy Rating, $32 Price Target

MT Newswires Live

Pharvaris Announces 2025 Annual Shareholders Meeting Amidst Phase 3 Trials

Press Release: Pharvaris Announces Annual Meeting of Shareholders

Pharvaris NV Publishes 2024 Annual Report

Analysts Offer Insights on Healthcare Companies: Cullinan Management (CGEM), aTyr Pharma (ATYR) and Pharvaris (PHVS)

Wedbush Keeps Their Buy Rating on Pharvaris (PHVS)

Pharvaris Price Target Maintained With a $27.00/Share by Wedbush

Pharvaris presents data supporting ongoing clinical development of deucrictibant

Pharvaris NV to Present Deucrictibant Clinical and Biomarker Data at C1-Inhibitor Deficiency and Angioedema Workshop

Stock Track | Pharvaris N.V. Plummets 5.15% After Q1 Earnings Miss and Conflicting Analyst Reports

Stock Track | Pharvaris N.V. Plummets 5.15% After Disappointing Q1 Results and Analyst Price Target Cut

Pharvaris Is Maintained at Overweight by Cantor Fitzgerald

Wedbush Adjusts Pharvaris Price Target to $17 From $25, Maintains Outperform Rating

MT Newswires Live

Pharvaris Nv : Wedbush Raises Target Price to $27 From $25

THOMSON REUTERS

Pharvaris Q1 EPS $(0.89) Misses $(0.82) Estimate

BRIEF-Pharvaris Reports First Quarter 2025 Financial Results and Provides Business Update

Pharvaris Reports Q1 2025 Financials and Advances HAE Treatment Trials

Pharvaris NV Reports Q1 2025 Loss of €46.3M and EPS of €0.85, Up from €28.0M Loss and €0.52 EPS in Q1 2024

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/PHVS/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PHVS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PHVS\",,,,,undefined,":{"symbol":"PHVS","market":"US","secType":"STK","nameCN":"Pharvaris N.V.","latestPrice":16.64,"timestamp":1750276800000,"preClose":16.56,"halted":0,"volume":6244,"hourTrading":{"tag":"盘后","latestPrice":16.64,"preClose":16.64,"latestTime":"16:04 EDT","volume":218,"amount":3627.52,"timestamp":1750277041383},"delay":0,"floatShares":21230522,"shares":54493142,"eps":-3.041696,"marketStatus":"Post-Mkt","change":0.08,"latestTime":"06-18 19:25:24 EDT","open":16.33,"high":17.1899,"low":16,"amount":103911.3435,"amplitude":0.071854,"askPrice":26.78,"askSize":200,"bidPrice":9.19,"bidSize":30,"shortable":3,"etf":0,"ttmEps":-3.041696,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1750291200000},"marketStatusCode":4,"adr":0,"listingDate":1612501200000,"exchange":"NASDAQ","adjPreClose":16.56,"postHourTrading":{"tag":"盘后","latestPrice":16.64,"preClose":16.64,"latestTime":"16:04 EDT","volume":218,"amount":3627.52,"timestamp":1750277041383},"volumeRatio":0.422223},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PHVS\",,,,,undefined,":{"symbol":"PHVS","floatShares":21230522,"roa":"-31.88%","roe":"-52.20%","lyrEps":-2.572355,"volumeRatio":0.422223,"shares":54493142,"dividePrice":0,"high":17.1899,"amplitude":0.071854,"preClose":16.56,"low":16,"week52Low":11.51,"pbRate":"3.50","week52High":25.4985,"institutionHeld":0,"latestPrice":16.64,"committee":-0.73913,"eps":-3.041696,"divideRate":0,"volume":6244,"delay":0,"ttmEps":-3.041696,"open":16.33,"prevYearClose":19.17,"prevWeekClose":16.7,"prevMonthClose":16.6,"prevQuarterClose":15.7,"fiveDayClose":17.05,"twentyDayClose":17.25,"sixtyDayClose":15.47},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PHVS\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2543799576","title":"Pharvaris Unveils Promising Data on Deucrictibant for Bradykinin-Mediated Angioedema at EAACI Congress 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2543799576","media":"Reuters","labels":["productRelease","conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543799576?lang=en_us&edition=fundamental","pubTime":"2025-06-16 18:50","pubTimestamp":1750071021,"startTime":"0","endTime":"0","summary":"Pharvaris NV , a late-stage biopharmaceutical company, has announced the presentation of data at the European Academy of Allergy and Clinical Immunology  Congress 2025, highlighting the potential of deucrictibant in preventing and treating bradykinin-mediated angioedema attacks. The data demonstrated deucrictibant's potential to address unmet needs for individuals with bradykinin-mediated diseases, such as hereditary angioedema  and acquired angioedema due to C1 inhibitor deficiency . The findings from the CHAPTER-1 and RAPIDe-2 studies indicated sustained attack reduction and improvement in quality of life. Additionally, the upcoming RAPIDe-3 phase 3 on-demand study will explore \"end-of-progression\" as a new pre-specified endpoint. Currently, there are no approved therapies for AAE-C1INH attacks, and Pharvaris' research aims to fill this gap. The posters with detailed findings are available on the Pharvaris website.Disclaimer: This news brief was created by Public Technologies  using ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250616:nNDL37n2Yk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","BK4588","IE00BGHQF748.EUR","BK4585","BK4007","PHVS","IE00B64PRP62.GBP","LU2210150020.SGD","LU2095319765.USD","LU2210149790.SGD","BK4112","IE00B3QW5Z07.USD","IE00BKPKM429.USD"],"gpt_icon":0},{"id":"2542582625","title":"Pharvaris initiated with a Buy at Guggenheim on HAE potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2542582625","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542582625?lang=en_us&edition=fundamental","pubTime":"2025-06-11 20:45","pubTimestamp":1749645919,"startTime":"0","endTime":"0","summary":"As previously reported, Guggenheim initiated coverage of Pharvaris (PHVS) with a Buy rating and $32 price target telling investors that the company...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/pharvaris-initiated-with-a-buy-at-guggenheim-on-hae-potential-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/pharvaris-initiated-with-a-buy-at-guggenheim-on-hae-potential-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","LU0012050646.USD","IE00BLDYK493.USD","BK4198","IE00B64QTZ34.USD","PHVS","HAE","LU0205194284.USD","LU0205193047.USD","LU0106261612.USD","LU1169589451.USD","LU1169590202.USD"],"gpt_icon":0},{"id":"2542589660","title":"Guggenheim Initiates Coverage on Pharvaris With Buy Rating, $32 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2542589660","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542589660?lang=en_us&edition=fundamental","pubTime":"2025-06-11 19:34","pubTimestamp":1749641664,"startTime":"0","endTime":"0","summary":"Pharvaris N.V (PHVS) has an average rating of Buy and mean price target of $33.19, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PHVS"],"gpt_icon":0},{"id":"2542193483","title":"Pharvaris Announces 2025 Annual Shareholders Meeting Amidst Phase 3 Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2542193483","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542193483?lang=en_us&edition=fundamental","pubTime":"2025-06-10 19:17","pubTimestamp":1749554253,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Pharvaris ( ($PHVS) ). On June 10, 2025, Pharvaris announced its annual general meeting of shareholders schedul...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pharvaris-announces-2025-annual-shareholders-meeting-amidst-phase-3-trials?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pharvaris-announces-2025-annual-shareholders-meeting-amidst-phase-3-trials?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PHVS","BK4007"],"gpt_icon":0},{"id":"2542467315","title":"Press Release: Pharvaris Announces Annual Meeting of Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2542467315","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542467315?lang=en_us&edition=fundamental","pubTime":"2025-06-10 18:50","pubTimestamp":1749552600,"startTime":"0","endTime":"0","summary":"ZUG, Switzerland, June 10, 2025  -- Pharvaris , a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs of those living with bradykinin-mediated diseases such as hereditary angioedema  and acquired angioedema due to C1 inhibitor deficiency , today announced the annual general meeting of shareholders will take place on Friday, June 27, 2025, at 16:00 CEST .All relevant documents and information relating to the annual general meeting, including the notice and agenda for the annual general meeting, are or will be made available in the \"Investors\" section of Pharvaris' website under \"Events & Presentations\". The documents will also be made available on the SEC's website at www.sec.gov. Shareholders who wish to attend the meeting should register as described in the notice and agenda for the annual general meeting.Executive Director, Head of Corporate and Investor Communications","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1169589451.USD","BK4604","BK4099","BK4585","PHVS","LU0012050646.USD","TM","LU1169590202.USD","BK4555","LU0106261612.USD","IE00BLDYK493.USD","BK4198","HAE","LU0205193047.USD","BK4007","03160","BK4588","IE00B64QTZ34.USD","LU0205194284.USD"],"gpt_icon":0},{"id":"2542353553","title":"Pharvaris NV Publishes 2024 Annual Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2542353553","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542353553?lang=en_us&edition=fundamental","pubTime":"2025-06-10 06:18","pubTimestamp":1749507526,"startTime":"0","endTime":"0","summary":"Pharvaris N.V. has released its Annual Report for the fiscal year ending December 31, 2024. The report details the company's business activities, organizational structure, and operating results. It highlights the company's ongoing focus on research and development, which has been its principal expenditure since inception. Pharvaris has primarily financed its operations through the issuance of equity securities. The report also covers various risk factors and controls and procedures in place. The full report can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pharvaris NV published the original content used to generate this news brief on June 09, 2025, and is solely responsible for the information cont","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250609:nNDLbPJWZw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PHVS"],"gpt_icon":0},{"id":"2542611806","title":"Analysts Offer Insights on Healthcare Companies: Cullinan Management (CGEM), aTyr Pharma (ATYR) and Pharvaris (PHVS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2542611806","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542611806?lang=en_us&edition=fundamental","pubTime":"2025-06-09 15:50","pubTimestamp":1749455413,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Cullinan Management (CGEM – Research Report), aTyr P...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-cullinan-management-cgem-atyr-pharma-atyr-and-pharvaris-phvs-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-cullinan-management-cgem-atyr-pharma-atyr-and-pharvaris-phvs-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ATYR","CGEM","BK4007","BK4137","HCSG","PHVS"],"gpt_icon":0},{"id":"2541807130","title":"Wedbush Keeps Their Buy Rating on Pharvaris (PHVS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2541807130","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541807130?lang=en_us&edition=fundamental","pubTime":"2025-06-05 22:45","pubTimestamp":1749134719,"startTime":"0","endTime":"0","summary":"Wedbush analyst maintained a Buy rating on Pharvaris (PHVS – Research Report) today and set a price target of $27.00. The company’s shares opened t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wedbush-keeps-their-buy-rating-on-pharvaris-phvs-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wedbush-keeps-their-buy-rating-on-pharvaris-phvs-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PHVS"],"gpt_icon":0},{"id":"2541407590","title":"Pharvaris Price Target Maintained With a $27.00/Share by Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2541407590","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541407590?lang=en_us&edition=fundamental","pubTime":"2025-06-05 21:44","pubTimestamp":1749131040,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PHVS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 05, 2025 09:44 ET (13:44 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHVS"],"gpt_icon":0},{"id":"2540762715","title":"Pharvaris presents data supporting ongoing clinical development of deucrictibant","url":"https://stock-news.laohu8.com/highlight/detail?id=2540762715","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540762715?lang=en_us&edition=fundamental","pubTime":"2025-06-02 18:55","pubTimestamp":1748861742,"startTime":"0","endTime":"0","summary":"Pharvaris (PHVS) announced a summary of data that were presented at the 14th C1-Inhibitor Deficiency and Angioedema Workshop. “Additional analyses ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/pharvaris-presents-data-supporting-ongoing-clinical-development-of-deucrictibant-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/pharvaris-presents-data-supporting-ongoing-clinical-development-of-deucrictibant-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PHVS","BK4007"],"gpt_icon":0},{"id":"2536683418","title":"Pharvaris NV to Present Deucrictibant Clinical and Biomarker Data at C1-Inhibitor Deficiency and Angioedema Workshop","url":"https://stock-news.laohu8.com/highlight/detail?id=2536683418","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536683418?lang=en_us&edition=fundamental","pubTime":"2025-05-19 18:50","pubTimestamp":1747651812,"startTime":"0","endTime":"0","summary":"Pharvaris NV, a late-stage biopharmaceutical company, is set to present at the 14th C1-Inhibitor Deficiency and Angioedema Workshop in Budapest from May 29 to June 1, 2025. The company will share insights on the \"Clinical Validation of a Novel Biomarker Assay to Characterize Bradykinin-Mediated Angioedema in Prospective and Biobank Plasma Samples\" and the \"Long-Term Prophylactic Treatment With Oral Deucrictibant Improves Health-Related Quality of Life and Disease Control in Participants With Hereditary Angioedema: CHAPTER-1 Open-Label Extension Study.\". Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pharvaris NV published the original content used to generate this news brief via GlobeNewswire  on May 19, 2025, and is solely responsibl","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250519:nNDL1Lbmpq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","IE00B64PRP62.GBP","BK4585","LU2210149790.SGD","IE00BGHQF748.EUR","BK4007","BK4588","PHVS","NDAQ","IE00B3QW5Z07.USD","LU2095319765.USD","BK4112","IE00BKPKM429.USD"],"gpt_icon":0},{"id":"1164894540","title":"Stock Track | Pharvaris N.V. Plummets 5.15% After Q1 Earnings Miss and Conflicting Analyst Reports","url":"https://stock-news.laohu8.com/highlight/detail?id=1164894540","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164894540?lang=en_us&edition=fundamental","pubTime":"2025-05-14 22:58","pubTimestamp":1747234708,"startTime":"0","endTime":"0","summary":"Shares of Pharvaris N.V.  tumbled 5.15% in intraday trading, as investors reacted to the company's disappointing first-quarter earnings report and mixed signals from analysts. The biopharmaceutical company, which focuses on developing novel therapies for hereditary angioedema , faced significant selling pressure following the release of its financial results.Pharvaris reported a quarterly loss of $0.89 per share, missing the analyst consensus estimate of $0.82 by 8.54%. This represents a substan","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["PHVS"],"gpt_icon":0},{"id":"1195284900","title":"Stock Track | Pharvaris N.V. Plummets 5.15% After Disappointing Q1 Results and Analyst Price Target Cut","url":"https://stock-news.laohu8.com/highlight/detail?id=1195284900","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195284900?lang=en_us&edition=fundamental","pubTime":"2025-05-14 22:58","pubTimestamp":1747234705,"startTime":"0","endTime":"0","summary":"Shares of Pharvaris N.V.  tumbled 5.15% in intraday trading, as investors reacted to the company's disappointing first-quarter financial results and a subsequent analyst price target reduction.The clinical-stage biopharmaceutical company reported quarterly losses of $0.89 per share, missing the analyst consensus estimate of $0.82 by 8.54%. This represents a significant increase in losses compared to the same period last year when the company reported a loss of $0.56 per share. The wider-than-exp","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"Stock Track | Pharvaris N.V. Plummets 5.15% After Disappointing Q1 Results and Analyst Price Target Cut","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["PHVS"],"gpt_icon":0},{"id":"2535076787","title":"Pharvaris Is Maintained at Overweight by Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2535076787","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535076787?lang=en_us&edition=fundamental","pubTime":"2025-05-14 22:46","pubTimestamp":1747233960,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PHVS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 14, 2025 10:46 ET (14:46 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHVS"],"gpt_icon":0},{"id":"2535102942","title":"Wedbush Adjusts Pharvaris Price Target to $17 From $25, Maintains Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2535102942","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535102942?lang=en_us&edition=fundamental","pubTime":"2025-05-14 20:30","pubTimestamp":1747225806,"startTime":"0","endTime":"0","summary":"Pharvaris N.V (PHVS) has an average rating of Buy and mean price target of $33.13, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PHVS"],"gpt_icon":0},{"id":"2535023564","title":"Pharvaris Nv : Wedbush Raises Target Price to $27 From $25","url":"https://stock-news.laohu8.com/highlight/detail?id=2535023564","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535023564?lang=en_us&edition=fundamental","pubTime":"2025-05-14 19:43","pubTimestamp":1747222984,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nFWN3RM1MA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PHVS","BK4007"],"gpt_icon":0},{"id":"2535060844","title":"Pharvaris Q1 EPS $(0.89) Misses $(0.82) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2535060844","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535060844?lang=en_us&edition=fundamental","pubTime":"2025-05-14 13:33","pubTimestamp":1747200831,"startTime":"0","endTime":"0","summary":"Pharvaris (NASDAQ:PHVS) reported quarterly losses of $(0.89) per share which missed the analyst consensus estimate of $(0.82) by 8.54 percent. This is a 58.93 percent decrease over losses of $(0.56) per share from the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45398099/pharvaris-q1-eps-0-89-misses-0-82-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHVS"],"gpt_icon":0},{"id":"2535087353","title":"BRIEF-Pharvaris Reports First Quarter 2025 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2535087353","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535087353?lang=en_us&edition=fundamental","pubTime":"2025-05-14 04:38","pubTimestamp":1747168703,"startTime":"0","endTime":"0","summary":"BRIEF-Pharvaris Reports First Quarter 2025 Financial Results and Provides Business UpdateMay 13 (Reuters) - Pharvaris NV PHVS.O:PHARVARIS N.V. Q1 EPS EUR -0.85 VERSUS. IBES ESTIMATE EUR -0.76Source text: ID:nGNX4ryTzjFurther company coverage: PHVS.O ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nPLXEB7000:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHVS","BK4007"],"gpt_icon":0},{"id":"2535879100","title":"Pharvaris Reports Q1 2025 Financials and Advances HAE Treatment Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2535879100","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535879100?lang=en_us&edition=fundamental","pubTime":"2025-05-14 04:33","pubTimestamp":1747168380,"startTime":"0","endTime":"0","summary":"An announcement from Pharvaris ( ($PHVS) ) is now available. On May 13, 2025, Pharvaris announced its financial results for the first quarter of 20...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pharvaris-reports-q1-2025-financials-and-advances-hae-treatment-trials?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pharvaris-reports-q1-2025-financials-and-advances-hae-treatment-trials?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PHVS","LU0205194284.USD","HAE","LU0205193047.USD","LU1169590202.USD","LU0106261612.USD","LU0012050646.USD","BK4007","IE00B64QTZ34.USD","BK4198","LU1169589451.USD","IE00BLDYK493.USD"],"gpt_icon":0},{"id":"2535084322","title":"Pharvaris NV Reports Q1 2025 Loss of €46.3M and EPS of €0.85, Up from €28.0M Loss and €0.52 EPS in Q1 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2535084322","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535084322?lang=en_us&edition=fundamental","pubTime":"2025-05-14 04:08","pubTimestamp":1747166915,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pharvaris NV published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 13, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nNDL8dWmFt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHVS"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":56,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PHVS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-13","symbol":"PHVS","fiscalQuarterEnding":"2025/03","expectedEps":-0.8,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"post","actualEps":-0.89},{"market":"US","date":"2025-04-07","symbol":"PHVS","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1743998400000,"reportTimeType":"pre","actualEps":-0.68},{"market":"US","date":"2024-11-13","symbol":"PHVS","fiscalQuarterEnding":"2024/09","expectedEps":-0.66,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"post","actualEps":-0.85},{"market":"US","date":"2024-08-14","symbol":"PHVS","fiscalQuarterEnding":"2024/06","expectedEps":-0.57,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723608000000,"reportTimeType":"pre","actualEps":-0.59},{"market":"US","date":"2024-05-08","symbol":"PHVS","fiscalQuarterEnding":"2024/03","expectedEps":-0.56,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715140800000,"reportTimeType":"post","actualEps":-0.56}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PHVS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PHVS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5455,"buy":0.3636,"hold":0,"sell":0.0909,"strongSell":0,"meanLabel":"BUY","meanPercent":0.3636,"analysts":11,"updateTime":1749700800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PHVS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PHVS","date":"2025-06-17","current":-5.257065,"percent":0.857681,"low":-57.487033,"twenty":-13.493044,"median":-8.964455,"eighty":-5.813948,"high":-1.271834,"avg":-11.267559,"sd":8.918655,"marketCap":924203688},"quantilePoints":[{"date":"2021-02-05","current":-40.655528,"twenty":-35.191346,"median":-26.995074,"eighty":-13.361825,"marketCap":923353504},{"date":"2021-02-12","current":-38.556139,"twenty":-42.255967,"median":-39.971365,"eighty":-31.6195,"marketCap":882252961},{"date":"2021-02-19","current":-51.857545,"twenty":-43.656687,"median":-39.971365,"eighty":-36.938628,"marketCap":1187915404},{"date":"2021-02-26","current":-55.014362,"twenty":-51.321142,"median":-43.322927,"eighty":-38.567599,"marketCap":1256722534},{"date":"2021-03-05","current":-42.283482,"twenty":-54.697812,"median":-44.160099,"eighty":-38.836179,"marketCap":951060091},{"date":"2021-03-12","current":-45.331857,"twenty":-53.116798,"median":-43.740127,"eighty":-39.776385,"marketCap":1022182845},{"date":"2021-03-19","current":-48.948372,"twenty":-52.354204,"median":-44.955963,"eighty":-40.021819,"marketCap":1099921670},{"date":"2021-03-26","current":-38.967887,"twenty":-51.682886,"median":-44.895337,"eighty":-39.792548,"marketCap":867697606},{"date":"2021-04-01","current":-41.621102,"twenty":-50.984249,"median":-43.918021,"eighty":-39.727138,"marketCap":924595810},{"date":"2021-04-09","current":-41.75527,"twenty":-50.647351,"median":-43.315034,"eighty":-39.727138,"marketCap":936835540},{"date":"2021-04-16","current":-40.837748,"twenty":-50.494041,"median":-42.658519,"eighty":-39.747341,"marketCap":923603399},{"date":"2021-04-23","current":-37.900499,"twenty":-49.17553,"median":-42.026105,"eighty":-38.829918,"marketCap":863066357},{"date":"2021-04-30","current":-25.541319,"twenty":-48.948372,"median":-41.646601,"eighty":-37.900499,"marketCap":798399091},{"date":"2021-05-07","current":-23.738176,"twenty":-48.895342,"median":-41.104912,"eighty":-36.326921,"marketCap":749700059},{"date":"2021-05-14","current":-22.435939,"twenty":-48.511867,"median":-40.837748,"eighty":-33.58931,"marketCap":707626746},{"date":"2021-05-21","current":-21.234553,"twenty":-47.818543,"median":-40.295032,"eighty":-26.156611,"marketCap":672510437},{"date":"2021-05-28","current":-19.380576,"twenty":-45.432957,"median":-39.747341,"eighty":-24.421758,"marketCap":679136156},{"date":"2021-06-04","current":-19.347354,"twenty":-45.352077,"median":-38.967887,"eighty":-23.463638,"marketCap":676817154},{"date":"2021-06-11","current":-19.412718,"twenty":-44.982641,"median":-38.721678,"eighty":-21.843417,"marketCap":675160725},{"date":"2021-06-18","current":-18.174436,"twenty":-44.643123,"median":-38.260176,"eighty":-21.113619,"marketCap":619504689},{"date":"2021-06-25","current":-17.828602,"twenty":-44.050431,"median":-37.439407,"eighty":-19.442186,"marketCap":612216398},{"date":"2021-07-02","current":-15.85879,"twenty":-43.775706,"median":-36.326921,"eighty":-19.370104,"marketCap":539996065},{"date":"2021-07-09","current":-14.490358,"twenty":-43.489807,"median":-35.672294,"eighty":-19.194795,"marketCap":494278607},{"date":"2021-07-16","current":-13.876053,"twenty":-43.313455,"median":-30.292192,"eighty":-19.061523,"marketCap":471088592},{"date":"2021-07-23","current":-14.202744,"twenty":-43.303543,"median":-26.3148,"eighty":-18.384979,"marketCap":480364598},{"date":"2021-07-30","current":-12.988167,"twenty":-42.915569,"median":-25.765358,"eighty":-18.050979,"marketCap":588695097},{"date":"2021-08-06","current":-11.844555,"twenty":-42.476534,"median":-24.421758,"eighty":-16.85205,"marketCap":532376489},{"date":"2021-08-13","current":-12.144906,"twenty":-42.312174,"median":-23.50716,"eighty":-15.514047,"marketCap":547615642},{"date":"2021-08-20","current":-12.372065,"twenty":-41.974629,"median":-22.435939,"eighty":-14.676752,"marketCap":552253645},{"date":"2021-08-27","current":-14.6624,"twenty":-41.760653,"median":-21.796739,"eighty":-14.375312,"marketCap":660584144},{"date":"2021-09-03","current":-13.869765,"twenty":-41.690069,"median":-21.159134,"eighty":-14.206363,"marketCap":629774552},{"date":"2021-09-10","current":-14.483783,"twenty":-41.636401,"median":-21.097683,"eighty":-14.200739,"marketCap":654620997},{"date":"2021-09-17","current":-13.408551,"twenty":-41.415194,"median":-19.619941,"eighty":-14.095163,"marketCap":601399913},{"date":"2021-09-24","current":-13.735189,"twenty":-41.105195,"median":-19.412718,"eighty":-13.917369,"marketCap":614535400},{"date":"2021-10-01","current":-13.275187,"twenty":-41.073352,"median":-19.361573,"eighty":-13.752501,"marketCap":588032525},{"date":"2021-10-08","current":-11.567624,"twenty":-40.951984,"median":-19.206349,"eighty":-13.609193,"marketCap":511505475},{"date":"2021-10-15","current":-11.808567,"twenty":-40.76486,"median":-19.158657,"eighty":-13.358075,"marketCap":523431769},{"date":"2021-10-22","current":-11.367098,"twenty":-40.543106,"median":-18.996962,"eighty":-13.26419,"marketCap":505211043},{"date":"2021-10-29","current":-13.069107,"twenty":-40.31092,"median":-18.615071,"eighty":-13.235325,"marketCap":577431375},{"date":"2021-11-05","current":-11.318661,"twenty":-40.118706,"median":-18.174436,"eighty":-12.989342,"marketCap":499744825},{"date":"2021-11-12","current":-12.526544,"twenty":-39.882961,"median":-18.037659,"eighty":-12.809718,"marketCap":547946928},{"date":"2021-11-19","current":-11.924212,"twenty":-39.73926,"median":-17.467833,"eighty":-12.433857,"marketCap":515812193},{"date":"2021-11-26","current":-10.362749,"twenty":-39.575288,"median":-16.707882,"eighty":-12.294384,"marketCap":448064220},{"date":"2021-12-03","current":-11.26034,"twenty":-38.958466,"median":-15.822297,"eighty":-12.166304,"marketCap":485665173},{"date":"2021-12-10","current":-11.449501,"twenty":-38.90261,"median":-15.106412,"eighty":-12.085176,"marketCap":494941179},{"date":"2021-12-17","current":-11.918983,"twenty":-38.786622,"median":-14.824901,"eighty":-12.032102,"marketCap":513493191},{"date":"2021-12-23","current":-12.067526,"twenty":-38.613439,"median":-14.809703,"eighty":-12.04158,"marketCap":521775339},{"date":"2021-12-31","current":-10.970608,"twenty":-38.556139,"median":-14.6624,"eighty":-12.029733,"marketCap":476720453},{"date":"2022-01-07","current":-14.755715,"twenty":-38.260176,"median":-14.556631,"eighty":-12.04158,"marketCap":639381844},{"date":"2022-01-14","current":-13.648303,"twenty":-37.900499,"median":-14.301086,"eighty":-12.059144,"marketCap":595652102},{"date":"2022-01-21","current":-13.462107,"twenty":-37.887735,"median":-14.301086,"eighty":-12.06585,"marketCap":583394522},{"date":"2022-01-28","current":-13.205088,"twenty":-37.172324,"median":-14.201073,"eighty":-12.067932,"marketCap":563186081},{"date":"2022-02-04","current":-13.024782,"twenty":-36.626254,"median":-14.120681,"eighty":-12.079807,"marketCap":569480513},{"date":"2022-02-11","current":-13.759795,"twenty":-36.368387,"median":-14.065459,"eighty":-12.092451,"marketCap":599627533},{"date":"2022-02-18","current":-13.388638,"twenty":-36.150333,"median":-14.023379,"eighty":-12.098608,"marketCap":579750377},{"date":"2022-02-25","current":-13.305926,"twenty":-35.845851,"median":-13.954525,"eighty":-12.116084,"marketCap":572793372},{"date":"2022-03-04","current":-14.115965,"twenty":-35.670778,"median":-13.938377,"eighty":-12.137788,"marketCap":588695097},{"date":"2022-03-11","current":-13.463028,"twenty":-34.421493,"median":-13.892451,"eighty":-12.149516,"marketCap":563186081},{"date":"2022-03-18","current":-14.218002,"twenty":-29.632768,"median":-13.881977,"eighty":-12.157248,"marketCap":600952677},{"date":"2022-03-25","current":-13.943073,"twenty":-26.658074,"median":-13.883771,"eighty":-12.178203,"marketCap":585382238},{"date":"2022-04-01","current":-12.747151,"twenty":-26.362243,"median":-13.880091,"eighty":-12.194172,"marketCap":601209361},{"date":"2022-04-08","current":-13.160374,"twenty":-26.219887,"median":-13.869765,"eighty":-12.198767,"marketCap":611652204},{"date":"2022-04-14","current":-12.64181,"twenty":-26.010325,"median":-13.786628,"eighty":-12.200601,"marketCap":583804624},{"date":"2022-04-22","current":-12.23556,"twenty":-25.770465,"median":-13.764494,"eighty":-12.203958,"marketCap":563581977},{"date":"2022-04-29","current":-12.580911,"twenty":-25.660418,"median":-13.730786,"eighty":-12.217679,"marketCap":566542439},{"date":"2022-05-06","current":-12.310085,"twenty":-25.093495,"median":-13.707219,"eighty":-12.233824,"marketCap":557283119},{"date":"2022-05-13","current":-10.422165,"twenty":-24.148325,"median":-13.655613,"eighty":-12.198139,"marketCap":571878572},{"date":"2022-05-20","current":-10.134271,"twenty":-23.650401,"median":-13.608097,"eighty":-12.152353,"marketCap":563590477},{"date":"2022-05-27","current":-10.266885,"twenty":-23.509475,"median":-13.570194,"eighty":-12.096742,"marketCap":579835143},{"date":"2022-06-03","current":-10.984203,"twenty":-23.463638,"median":-13.4682,"eighty":-12.07039,"marketCap":620612572},{"date":"2022-06-10","current":-12.843347,"twenty":-23.155882,"median":-13.459721,"eighty":-12.067627,"marketCap":712444667},{"date":"2022-06-17","current":-16.528573,"twenty":-22.410251,"median":-13.457335,"eighty":-12.07039,"marketCap":911690477},{"date":"2022-06-24","current":-12.484354,"twenty":-22.307498,"median":-13.442896,"eighty":-12.079819,"marketCap":694210858},{"date":"2022-07-01","current":-14.299351,"twenty":-21.874535,"median":-13.402807,"eighty":-12.068033,"marketCap":784053810},{"date":"2022-07-08","current":-14.094213,"twenty":-21.750061,"median":-13.450115,"eighty":-12.077462,"marketCap":756209125},{"date":"2022-07-15","current":-14.396825,"twenty":-21.331431,"median":-13.463028,"eighty":-12.082165,"marketCap":765820001},{"date":"2022-07-22","current":-13.29424,"twenty":-21.174218,"median":-13.473474,"eighty":-12.092451,"marketCap":716422953},{"date":"2022-07-29","current":-13.469033,"twenty":-21.125909,"median":-13.4682,"eighty":-12.098608,"marketCap":724213762},{"date":"2022-08-05","current":-11.76507,"twenty":-21.101667,"median":-13.459721,"eighty":-12.082165,"marketCap":629895239},{"date":"2022-08-12","current":-10.43948,"twenty":-20.186916,"median":-13.408551,"eighty":-12.055631,"marketCap":564253524},{"date":"2022-08-19","current":-11.581834,"twenty":-19.826532,"median":-13.395996,"eighty":-12.028713,"marketCap":612987524},{"date":"2022-08-26","current":-5.820227,"twenty":-19.515891,"median":-13.372919,"eighty":-11.990749,"marketCap":306659524},{"date":"2022-09-02","current":-5.892736,"twenty":-19.429171,"median":-13.356682,"eighty":-11.943475,"marketCap":311632381},{"date":"2022-09-09","current":-5.834763,"twenty":-19.417564,"median":-13.345814,"eighty":-11.915113,"marketCap":308814429},{"date":"2022-09-16","current":-6.129031,"twenty":-19.393433,"median":-13.317212,"eighty":-11.844209,"marketCap":307945619},{"date":"2022-09-23","current":-5.527907,"twenty":-19.377706,"median":-13.304479,"eighty":-11.805952,"marketCap":269452416},{"date":"2022-09-30","current":-5.268219,"twenty":-19.358729,"median":-13.29424,"eighty":-11.739355,"marketCap":258984966},{"date":"2022-10-07","current":-3.334511,"twenty":-19.313349,"median":-13.281408,"eighty":-11.574558,"marketCap":163427280},{"date":"2022-10-14","current":-3.192899,"twenty":-19.240081,"median":-13.26552,"eighty":-11.519941,"marketCap":155998767},{"date":"2022-10-21","current":-3.776992,"twenty":-19.189017,"median":-13.2607,"eighty":-11.419826,"marketCap":185712818},{"date":"2022-10-28","current":-3.404363,"twenty":-19.175941,"median":-13.241782,"eighty":-11.34035,"marketCap":169704373},{"date":"2022-11-04","current":-2.493588,"twenty":-19.155403,"median":-13.21909,"eighty":-11.293284,"marketCap":123921098},{"date":"2022-11-11","current":-1.962841,"twenty":-19.119693,"median":-13.202703,"eighty":-11.220822,"marketCap":101635560},{"date":"2022-11-18","current":-1.709372,"twenty":-19.040002,"median":-13.169144,"eighty":-11.073401,"marketCap":88804493},{"date":"2022-11-25","current":-1.59989,"twenty":-18.960552,"median":-13.089194,"eighty":-10.924331,"marketCap":83401938},{"date":"2022-12-02","current":-1.271834,"twenty":-18.879299,"median":-13.066255,"eighty":-10.549888,"marketCap":66856614},{"date":"2022-12-09","current":-5.585763,"twenty":-18.659925,"median":-13.055482,"eighty":-10.38824,"marketCap":291250318},{"date":"2022-12-16","current":-4.830297,"twenty":-18.384979,"median":-13.024782,"eighty":-10.32247,"marketCap":253408050},{"date":"2022-12-23","current":-6.371604,"twenty":-18.295522,"median":-12.990589,"eighty":-10.187317,"marketCap":334836503},{"date":"2022-12-30","current":-7.188594,"twenty":-18.170479,"median":-12.982972,"eighty":-10.008759,"marketCap":380112075},{"date":"2023-01-06","current":-7.688928,"twenty":-18.154652,"median":-12.903124,"eighty":-9.752954,"marketCap":403763493},{"date":"2023-01-13","current":-5.706058,"twenty":-18.104257,"median":-12.846213,"eighty":-7.688928,"marketCap":305441169},{"date":"2023-01-20","current":-6.459312,"twenty":-17.9977,"median":-12.837332,"eighty":-7.374204,"marketCap":346324335},{"date":"2023-01-27","current":-5.951135,"twenty":-17.857094,"median":-12.821298,"eighty":-6.862976,"marketCap":319632020},{"date":"2023-02-03","current":-5.776873,"twenty":-17.539987,"median":-12.756949,"eighty":-6.367933,"marketCap":310171453},{"date":"2023-02-10","current":-6.06212,"twenty":-17.052096,"median":-12.693639,"eighty":-6.243368,"marketCap":320307775},{"date":"2023-02-17","current":-5.565251,"twenty":-16.755938,"median":-12.64181,"eighty":-6.151395,"marketCap":293615460},{"date":"2023-02-24","current":-5.080906,"twenty":-16.600297,"median":-12.612561,"eighty":-6.08797,"marketCap":265233759},{"date":"2023-03-03","current":-5.604926,"twenty":-16.439572,"median":-12.581052,"eighty":-6.019199,"marketCap":293953338},{"date":"2023-03-10","current":-4.059398,"twenty":-16.126823,"median":-12.554737,"eighty":-5.957727,"marketCap":214214271},{"date":"2023-03-17","current":-4.759844,"twenty":-15.898426,"median":-12.5386,"eighty":-5.915214,"marketCap":251042908},{"date":"2023-03-24","current":-4.748457,"twenty":-15.814998,"median":-12.484354,"eighty":-5.839251,"marketCap":252732295},{"date":"2023-03-31","current":-5.062872,"twenty":-15.558556,"median":-12.41617,"eighty":-5.818726,"marketCap":272160245},{"date":"2023-04-06","current":-5.515395,"twenty":-15.2868,"median":-12.393076,"eighty":-5.798276,"marketCap":298007866},{"date":"2023-04-14","current":-3.407139,"twenty":-15.104598,"median":-12.376683,"eighty":-5.751686,"marketCap":287439901},{"date":"2023-04-21","current":-3.423024,"twenty":-15.075219,"median":-12.365371,"eighty":-5.695738,"marketCap":286594490},{"date":"2023-04-28","current":-3.621546,"twenty":-14.971826,"median":-12.310085,"eighty":-5.661512,"marketCap":304686295},{"date":"2023-05-05","current":-3.635585,"twenty":-14.858222,"median":-12.26867,"eighty":-5.593428,"marketCap":305362624},{"date":"2023-05-12","current":-3.330904,"twenty":-14.826016,"median":-12.249364,"eighty":-5.568587,"marketCap":277633128},{"date":"2023-05-19","current":-3.332274,"twenty":-14.818952,"median":-12.234113,"eighty":-5.5204,"marketCap":297584839},{"date":"2023-05-26","current":-3.231497,"twenty":-14.811441,"median":-12.222059,"eighty":-5.439393,"marketCap":287439901},{"date":"2023-06-02","current":-3.434585,"twenty":-14.791955,"median":-12.201472,"eighty":-5.312927,"marketCap":305832502},{"date":"2023-06-09","current":-3.407273,"twenty":-14.764775,"median":-12.198453,"eighty":-5.28475,"marketCap":304479261},{"date":"2023-06-16","current":-4.170938,"twenty":-14.740265,"median":-12.160354,"eighty":-5.07843,"marketCap":377892593},{"date":"2023-06-23","current":-4.359744,"twenty":-14.731325,"median":-12.152393,"eighty":-5.057591,"marketCap":396297439},{"date":"2023-06-30","current":-7.00064,"twenty":-14.718305,"median":-12.136009,"eighty":-5.055831,"marketCap":632126719},{"date":"2023-07-07","current":-7.084548,"twenty":-14.696694,"median":-12.097209,"eighty":-5.062872,"marketCap":638244074},{"date":"2023-07-14","current":-6.875228,"twenty":-14.6624,"median":-12.079819,"eighty":-5.068525,"marketCap":638244074},{"date":"2023-07-21","current":-7.028003,"twenty":-14.653302,"median":-12.064139,"eighty":-5.080906,"marketCap":649663138},{"date":"2023-07-28","current":-7.498848,"twenty":-14.622905,"median":-12.04158,"eighty":-5.207419,"marketCap":683512504},{"date":"2023-08-04","current":-7.953511,"twenty":-14.601036,"median":-12.024634,"eighty":-5.228713,"marketCap":722255754},{"date":"2023-08-11","current":-7.354477,"twenty":-14.583407,"median":-11.998532,"eighty":-5.261383,"marketCap":747059362},{"date":"2023-08-18","current":-7.862758,"twenty":-14.572779,"median":-11.956319,"eighty":-5.28475,"marketCap":788698737},{"date":"2023-08-25","current":-7.637624,"twenty":-14.506463,"median":-11.943194,"eighty":-5.298861,"marketCap":762796904},{"date":"2023-08-31","current":-8.133422,"twenty":-14.4867,"median":-11.921598,"eighty":-5.305964,"marketCap":813459365},{"date":"2023-09-08","current":-7.866907,"twenty":-14.484166,"median":-11.909309,"eighty":-5.312927,"marketCap":776279656},{"date":"2023-09-15","current":-8.565073,"twenty":-14.483879,"median":-11.869315,"eighty":-5.324599,"marketCap":842467710},{"date":"2023-09-22","current":-8.218785,"twenty":-14.422991,"median":-11.843691,"eighty":-5.364732,"marketCap":808147978},{"date":"2023-09-29","current":-8.499622,"twenty":-14.407261,"median":-11.810464,"eighty":-5.391254,"marketCap":828167822},{"date":"2023-10-06","current":-8.075664,"twenty":-14.404891,"median":-11.805298,"eighty":-5.421144,"marketCap":784042452},{"date":"2023-10-13","current":-7.97887,"twenty":-14.393189,"median":-11.762441,"eighty":-5.494747,"marketCap":776279656},{"date":"2023-10-20","current":-7.871535,"twenty":-14.374592,"median":-11.67635,"eighty":-5.497417,"marketCap":767699722},{"date":"2023-10-27","current":-7.699507,"twenty":-14.37054,"median":-11.628617,"eighty":-5.497654,"marketCap":747679879},{"date":"2023-11-03","current":-7.17043,"twenty":-14.351862,"median":-11.573402,"eighty":-5.505177,"marketCap":701920236},{"date":"2023-11-10","current":-5.970942,"twenty":-14.325681,"median":-11.546094,"eighty":-5.518658,"marketCap":686476556},{"date":"2023-11-17","current":-5.487665,"twenty":-14.300392,"median":-11.499199,"eighty":-5.518658,"marketCap":639755166},{"date":"2023-11-24","current":-5.931936,"twenty":-14.283081,"median":-11.456561,"eighty":-5.501771,"marketCap":694263454},{"date":"2023-12-01","current":-6.025826,"twenty":-14.216157,"median":-11.367098,"eighty":-5.517027,"marketCap":705329046},{"date":"2023-12-08","current":-11.439876,"twenty":-14.20757,"median":-11.347894,"eighty":-5.524424,"marketCap":1324602518},{"date":"2023-12-15","current":-11.41059,"twenty":-14.202076,"median":-11.375314,"eighty":-5.532271,"marketCap":1346488162},{"date":"2023-12-22","current":-11.925452,"twenty":-14.184853,"median":-11.42744,"eighty":-5.551316,"marketCap":1406934225},{"date":"2023-12-29","current":-12.247032,"twenty":-14.141201,"median":-11.449501,"eighty":-5.556079,"marketCap":1455916379},{"date":"2024-01-05","current":-11.217845,"twenty":-14.124263,"median":-11.444688,"eighty":-5.560701,"marketCap":1319391651},{"date":"2024-01-12","current":-13.194311,"twenty":-14.118795,"median":-11.460366,"eighty":-5.568587,"marketCap":1550325393},{"date":"2024-01-19","current":-14.465426,"twenty":-14.174814,"median":-11.47464,"eighty":-5.574125,"marketCap":1686754028},{"date":"2024-01-26","current":-14.983944,"twenty":-14.20757,"median":-11.499199,"eighty":-5.577066,"marketCap":1742861042},{"date":"2024-02-02","current":-15.192524,"twenty":-14.300739,"median":-11.528223,"eighty":-5.581389,"marketCap":1768847449},{"date":"2024-02-09","current":-14.748842,"twenty":-14.393189,"median":-11.54682,"eighty":-5.589596,"marketCap":1703881432},{"date":"2024-02-16","current":-13.65194,"twenty":-14.404891,"median":-11.567624,"eighty":-5.608959,"marketCap":1576311800},{"date":"2024-02-23","current":-14.13304,"twenty":-14.396825,"median":-11.581834,"eighty":-5.625092,"marketCap":1640687216},{"date":"2024-03-01","current":-10.303743,"twenty":-14.378644,"median":-11.573402,"eighty":-5.629721,"marketCap":1195373004},{"date":"2024-03-08","current":-12.093153,"twenty":-14.358385,"median":-11.567624,"eighty":-5.636181,"marketCap":1418455194},{"date":"2024-03-15","current":-10.896325,"twenty":-14.342077,"median":-11.552539,"eighty":-5.658684,"marketCap":1273758779},{"date":"2024-03-22","current":-11.538805,"twenty":-14.301086,"median":-11.546205,"eighty":-5.665753,"marketCap":1344762225},{"date":"2024-03-28","current":-10.904189,"twenty":-14.299698,"median":-11.538805,"eighty":-5.674035,"marketCap":1264076491},{"date":"2024-04-05","current":-10.349243,"twenty":-14.288877,"median":-11.507756,"eighty":-5.680711,"marketCap":1206520668},{"date":"2024-04-12","current":-11.107813,"twenty":-14.231653,"median":-11.490879,"eighty":-5.687459,"marketCap":1200065809},{"date":"2024-04-19","current":-9.215802,"twenty":-14.210621,"median":-11.46913,"eighty":-5.702618,"marketCap":991303742},{"date":"2024-04-26","current":-11.339937,"twenty":-14.20395,"median":-11.459096,"eighty":-5.715476,"marketCap":1225406418},{"date":"2024-05-03","current":-11.733497,"twenty":-14.200071,"median":-11.46913,"eighty":-5.724599,"marketCap":1266307115},{"date":"2024-05-10","current":-9.668623,"twenty":-14.189365,"median":-11.459096,"eighty":-5.733174,"marketCap":1107009662},{"date":"2024-05-17","current":-10.115404,"twenty":-14.156013,"median":-11.42744,"eighty":-5.759289,"marketCap":1168360708},{"date":"2024-05-24","current":-9.147602,"twenty":-14.136092,"median":-11.375314,"eighty":-5.774576,"marketCap":1052116621},{"date":"2024-05-31","current":-8.827191,"twenty":-14.129207,"median":-11.35501,"eighty":-5.782121,"marketCap":1017135762},{"date":"2024-06-07","current":-7.823819,"twenty":-14.123069,"median":-11.339823,"eighty":-5.787829,"marketCap":904658844},{"date":"2024-06-14","current":-8.515887,"twenty":-14.119026,"median":-11.316994,"eighty":-5.792437,"marketCap":974082396},{"date":"2024-06-21","current":-8.52603,"twenty":-14.116428,"median":-11.288753,"eighty":-5.797709,"marketCap":970853394},{"date":"2024-06-28","current":-8.52006,"twenty":-14.116197,"median":-11.262481,"eighty":-5.798843,"marketCap":969238893},{"date":"2024-07-05","current":-7.963908,"twenty":-14.11303,"median":-11.251924,"eighty":-5.805313,"marketCap":914884019},{"date":"2024-07-12","current":-8.497692,"twenty":-14.104041,"median":-11.224936,"eighty":-5.814579,"marketCap":981616735},{"date":"2024-07-15","current":-8.709438,"twenty":-14.101747,"median":-11.224715,"eighty":-5.815211,"marketCap":1010139590},{"date":"2024-08-02","current":-7.485095,"twenty":-14.099454,"median":-11.224493,"eighty":-5.815842,"marketCap":857838309},{"date":"2024-08-09","current":-7.640912,"twenty":-14.094802,"median":-11.205504,"eighty":-5.819476,"marketCap":885822997},{"date":"2024-08-16","current":-8.240501,"twenty":-14.093907,"median":-11.162588,"eighty":-5.823431,"marketCap":1032742607},{"date":"2024-08-23","current":-7.760367,"twenty":-14.048436,"median":-11.118035,"eighty":-5.826337,"marketCap":983480417},{"date":"2024-08-30","current":-7.393035,"twenty":-14.034683,"median":-11.087899,"eighty":-5.833183,"marketCap":934333400},{"date":"2024-09-06","current":-8.155019,"twenty":-14.033224,"median":-11.020127,"eighty":-5.839251,"marketCap":1031547280},{"date":"2024-09-13","current":-8.802104,"twenty":-14.027088,"median":-10.978779,"eighty":-5.849019,"marketCap":1108238229},{"date":"2024-09-20","current":-8.962749,"twenty":-13.99324,"median":-10.957045,"eighty":-5.877056,"marketCap":1139022624},{"date":"2024-09-27","current":-8.000083,"twenty":-13.961974,"median":-10.894902,"eighty":-5.894802,"marketCap":1020205660},{"date":"2024-10-04","current":-7.688355,"twenty":-13.947654,"median":-10.874176,"eighty":-5.909483,"marketCap":966197949},{"date":"2024-10-11","current":-7.725025,"twenty":-13.936046,"median":-10.812773,"eighty":-5.924083,"marketCap":962957487},{"date":"2024-10-18","current":-9.289256,"twenty":-13.925882,"median":-10.792815,"eighty":-5.928401,"marketCap":1147663858},{"date":"2024-10-25","current":-9.347449,"twenty":-13.904362,"median":-10.773913,"eighty":-5.930655,"marketCap":1151984475},{"date":"2024-10-31","current":-10.81176,"twenty":-13.888979,"median":-10.69668,"eighty":-5.935928,"marketCap":1339391232},{"date":"2024-11-08","current":-9.795031,"twenty":-13.882336,"median":-10.614452,"eighty":-5.945603,"marketCap":1205452109},{"date":"2024-11-15","current":-7.934741,"twenty":-13.880109,"median":-10.567811,"eighty":-5.951569,"marketCap":1109858461},{"date":"2024-11-22","current":-8.193559,"twenty":-13.878421,"median":-10.530141,"eighty":-5.955891,"marketCap":1136322239},{"date":"2024-11-29","current":-8.515548,"twenty":-13.874795,"median":-10.499116,"eighty":-5.962822,"marketCap":1187704999},{"date":"2024-12-06","current":-7.575701,"twenty":-13.869107,"median":-10.430822,"eighty":-5.969,"marketCap":1058630209},{"date":"2024-12-13","current":-7.438607,"twenty":-13.864864,"median":-10.405945,"eighty":-5.972,"marketCap":1031513657},{"date":"2024-12-20","current":-7.511117,"twenty":-13.847086,"median":-10.370165,"eighty":-5.976517,"marketCap":1030971326},{"date":"2024-12-27","current":-7.680726,"twenty":-13.801742,"median":-10.357252,"eighty":-5.977661,"marketCap":1057545547},{"date":"2025-01-03","current":-7.415916,"twenty":-13.792864,"median":-10.345951,"eighty":-6.00833,"marketCap":1005481766},{"date":"2025-01-10","current":-7.387777,"twenty":-13.788234,"median":-10.323543,"eighty":-6.019199,"marketCap":1005481766},{"date":"2025-01-17","current":-6.953437,"twenty":-13.781733,"median":-10.297117,"eighty":-6.023626,"marketCap":946367682},{"date":"2025-01-24","current":-7.612205,"twenty":-13.774759,"median":-10.284647,"eighty":-6.025423,"marketCap":1047783588},{"date":"2025-01-31","current":-6.977006,"twenty":-13.765434,"median":-10.25901,"eighty":-6.034301,"marketCap":961552951},{"date":"2025-02-07","current":-7.219276,"twenty":-13.753463,"median":-10.232674,"eighty":-6.052543,"marketCap":990296497},{"date":"2025-02-14","current":-6.822516,"twenty":-13.740454,"median":-10.115609,"eighty":-6.061351,"marketCap":942029033},{"date":"2025-02-21","current":-6.467941,"twenty":-13.734308,"median":-10.093087,"eighty":-6.062421,"marketCap":894846232},{"date":"2025-02-28","current":-6.133931,"twenty":-13.727465,"median":-10.02417,"eighty":-6.065143,"marketCap":843867113},{"date":"2025-03-07","current":-5.852269,"twenty":-13.71316,"median":-9.970579,"eighty":-6.049778,"marketCap":837901472},{"date":"2025-03-14","current":-6.385184,"twenty":-13.708332,"median":-9.910974,"eighty":-6.026825,"marketCap":917081805},{"date":"2025-03-21","current":-5.844642,"twenty":-13.700767,"median":-9.829627,"eighty":-6.025288,"marketCap":838443803},{"date":"2025-03-28","current":-5.916884,"twenty":-13.679442,"median":-9.795031,"eighty":-5.984934,"marketCap":844409444},{"date":"2025-04-04","current":-5.41793,"twenty":-13.665275,"median":-9.712775,"eighty":-5.969,"marketCap":792887995},{"date":"2025-04-11","current":-4.319691,"twenty":-13.654878,"median":-9.636637,"eighty":-5.953745,"marketCap":648468389},{"date":"2025-04-17","current":-4.898467,"twenty":-13.65194,"median":-9.603412,"eighty":-5.931936,"marketCap":747645908},{"date":"2025-04-25","current":-5.660159,"twenty":-13.648303,"median":-9.484661,"eighty":-5.916884,"marketCap":862626437},{"date":"2025-05-02","current":-6.426634,"twenty":-13.611466,"median":-9.396394,"eighty":-5.918352,"marketCap":972702584},{"date":"2025-05-09","current":-6.135697,"twenty":-13.604729,"median":-9.345786,"eighty":-5.927903,"marketCap":928563139},{"date":"2025-05-16","current":-5.081075,"twenty":-13.598948,"median":-9.280564,"eighty":-5.916884,"marketCap":866985889},{"date":"2025-05-23","current":-5.189286,"twenty":-13.570194,"median":-9.208581,"eighty":-5.882056,"marketCap":893142597},{"date":"2025-05-30","current":-5.256736,"twenty":-13.527456,"median":-9.173722,"eighty":-5.851134,"marketCap":911125334},{"date":"2025-06-06","current":-5.007101,"twenty":-13.509055,"median":-9.060878,"eighty":-5.837961,"marketCap":874614929},{"date":"2025-06-13","current":-5.317982,"twenty":-13.49872,"median":-8.982791,"eighty":-5.819476,"marketCap":938916836},{"date":"2025-06-17","current":-5.257065,"twenty":-13.493044,"median":-8.964455,"eighty":-5.813948,"marketCap":924203688}],"updateTime":1750254323835}}}